Lassa Fever Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial
PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, today announced it has dosed subjects in a Phase 1, first-in-human clinical trial to evaluate INO-4500, its DNA... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - May 21, 2019 Category: Pharmaceuticals Source Type: clinical trials

Cardiovascular Function and Ribavirin Pharmacokinetics and Pharmacodynamics in Patients With Lassa Fever
Condition:   Lassa Fever Intervention:   Drug: Ribavirin Sponsors:   University of Oxford;   National Institute for Health Research, United Kingdom;   Kenema Government Hospital;   London School of Hygiene and Tropical Medicine;   Public Health England Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials